HBV-specific peptide associated with heat-shock protein gp96

Lancet. 2001 Feb 17;357(9255):528-9. doi: 10.1016/S0140-6736(00)04050-2.

Abstract

Glycoprotein 96 (gp96), a member of the heat-shock protein family, can elicit priming of antigen-specfic cytotoxic T lymphocytes, when bound to antigenic viral or tumour peptides. We used direct peptide isolation from purified gp96 and microsequencing to show that a virus-specific peptide is bound to gp96 derived from liver tissues of patients with hepatitis B virus (HBV)-induced hepatocellular carcinoma. This virus-specific peptide has potential for engineering tumour vaccines against hepatocellular carcinoma and chronic HBV infection.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / metabolism*
  • Cancer Vaccines
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / virology
  • Heat-Shock Proteins / metabolism*
  • Hepatitis B / complications
  • Hepatitis B / metabolism*
  • Hepatitis B Core Antigens / metabolism*
  • Humans
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / virology
  • Peptide Fragments / metabolism
  • Protein Binding

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Heat-Shock Proteins
  • Hepatitis B Core Antigens
  • Peptide Fragments
  • sarcoma glycoprotein gp96 rejection antigens